Trial Profile
A phase I/II trial of CordIn along with a non-manipulated umbilical cord blood unit in a double graft configuration in patients with sickle cell disease
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Aug 2016
Price :
$35
*
At a glance
- Drugs Cord blood stem cell therapy (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions; Therapeutic Use
- 16 Aug 2016 New trial record
- 27 Jul 2016 According to a Gamida-Cell media release, eight patients were transplanted in double graft configuration and preliminary data from this trial will be summarized and published later in 2016.